Portfolio news 0

Enterprise Therapeutics

Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001

Quantum Motion Technologies

Quantum Motion Raises $160m Series C to Deliver Quantum Computing’s “Transistor Moment”

Ionix Advanced Technologies Ltd

Ionix’s sensing system the world’s most demanding industries rely on – HotSense – receives a King’s Award for Enterprise for Innovation

Barocal raises $10m to disrupt century-old cooling industry with breakthrough materials technology

First Light Fusion Ltd

First Light Fusion announces sale of VIPER III velocity amplifiers to Texas A&M Engineering Experiment Station

Hypervision Surgical

Hypervision Surgical Raises £17 Million Series A to Power Surgical Intelligence Through Hyperspectral Vision

Genomics

Greywolf Therapeutics and Genomics Launch Strategic Relationship to Develop First‑in‑Class Treatments for Autoimmune Diseases

Lumai

Lumai Launches the World’s First Optical Computing System for Real-Time, Billion-Parameter LLM Inference

First Light Fusion Ltd

Locai Labs signs contract with First Light Fusion for the supply of a domain-specific LLM for fusion energy research

Istesso Ltd

Istesso presents data showing that its first-in-class oral regenerative agent, leramistat, restores muscle quality beyond baseline in aging models